Cellebrite DI Ltd. (CLBT)

NASDAQ: CLBT · USD

$11.9

-0.04 (-0.3%)· Recorded snapshot

Market cap	3B
Revenue (ttm)	514.3M
Net income (ttm)	58.2M
EPS (ttm)	$0.23
Shares out	250.8M
P/E (trailing)	51.8x
P/E (forward)	19.4x
Volume	803,713
Beta	1.13

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 514.3M
Net income (ttm): 58.2M
EPS (ttm): $0.23
P/E (trailing): 51.8x
P/E (forward): 19.4x
Market cap: 3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E19.4

P25 n/aP50 n/aP75 n/a

Trailing P/E51.8

P25 n/aP50 n/aP75 n/a

ROE12.4

P25 n/aP50 n/aP75 n/a

ROIC39

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CLBT indicators

Market & fundamental data

Available fields

253

Groups with data

Currency

USD

Showing 253 of 253 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001854587
Company name	Cellebrite DI Ltd.
Country	Israel
Country code	US
CUSIP number	M2197Q107
Earnings date	2026-11-12
Earnings time	bmo
Employees	1,285
Employees change	118
Employees growth	10.11%
Enterprise value	$2.5B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1999
Industry	Software - Infrastructure
Is primary listing	Yes
Is SPAC	No
ISIN number	IL0011794802
Last 10-K release date	2026-03-03
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$3B
Market cap category	Mid-Cap
Next earnings date	2026-11-12
Options	Yes
Price	$11.89
Price currency	USD
Sector	Technology
SIC code	7372
Stock price date	2026-10-28
Symbol	CLBT
Website	https://www.cellebrite.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	23.31x
Earnings yield	1.93%
EV/Earnings	42.48x
EV/EBIT	44.29x
EV/EBITDA	31.55x
EV/FCF	17.16x
EV/Sales	4.81x
FCF / EV yield	5.83%
FCF yield	4.81%
Forward EV/Sales	4.12x
Forward P/E	19.38x
Forward P/S	4.99x
Graham number	3.32943
Graham upside	-72.14%
Industry forward P/E	29.48x
Industry P/E	39.18x
Lynch fair value	$5.74
Lynch upside	-51.96%
P/(FCF - SBC) ratio	34.36x
P/(OCF - SBC) ratio	29.78x
P/B ratio	5.56x
P/E ratio	51.78x
P/FCF ratio	20.79x
P/OCF ratio	19.02x
P/S ratio	5.83x
PEG ratio	1.1x
Price / tangible book value	10.1x
Price/EBITDA ratio	38.21x
Sector forward P/E	18.86x
Sector P/E	32.77x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	10.86%
EBITDA margin	15.25%
Effective tax rate	22.05%
FCF margin	28.03%
Gross margin	82.96%
Operating margin	10.86%
Pretax margin	14.66%
Profit margin	11.43%
Profit per employee	$45,328
Profitable quarters	7
Profitable years	1
Revenue per employee	$400,225
ROA	3.92%
ROA (5Y)	3.6%
ROCE	8.87%
ROE	12.42%
ROE (5Y)	9,302.96%
ROIC	39.04%
SBC / revenue	11.07%
Tax / revenue	3.23%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (Q)	-67.91%
EPS growth (QoQ)	-35.68%
EPS growth 5Y	39.21%
EPS growth years	1
FCF growth	-3.97%
FCF growth (Q)	-49.88%
FCF growth (QoQ)	-13.79%
FCF growth 3Y	34.44%
FCF growth 5Y	20.12%
Gross profit growth	15.78%
Gross profit growth (Q)	10.81%
Gross profit growth 3Y	20.89%
Gross profit growth 5Y	18.24%
Net income growth (Q)	-67.29%
Net income growth (QoQ)	-41.75%
Net income growth 5Y	51.35%
Net income growth years	1
OCF growth	-2.19%
OCF growth (Q)	-46.02%
OCF growth (QoQ)	-11.55%
OCF growth 3Y	34.86%
OCF growth 5Y	20.1%
Operating income growth	-9.69%
Operating income growth (Q)	-51.8%
Operating income growth 3Y	61.15%
Operating income growth 5Y	14.4%
Revenue growth	17.76%
Revenue growth (Q)	15.77%
Revenue growth (QoQ)	2.21%
Revenue growth 3Y	20.54%
Revenue growth 5Y	18.2%
Revenue growth quarters	20
Revenue growth years	6

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-13.4M
Depreciation and amortization	$22.6M
EBIT	$55.9M
EBITDA	$78.4M
EPS	$0.23
FCF per share	$0.57
Financing cash flow	$14.7M
Free cash flow	$144.2M
Free cash flow minus SBC	$87.2M
Gross profit	$426.7M
Income taxes	$16.6M
Investing cash flow	$-209.6M
Net cash flow	$-38M
Net income	$58.2M
Operating cash flow minus SBC	$100.6M
Operating income	$55.9M
Revenue	$514.3M
Stock-based compensation	$56.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	5.88
Book value per share	$2.15
Debt / EBITDA	0.27
Debt / equity	0.04
Debt / FCF	0.16
Goodwill	$119.6M
Long-term assets	$404.6M
Long-term liabilities	$92M
Net cash (debt)	$522.5M
Net cash / market cap	17.43%
Net cash growth	-2.43%
Net debt / EBITDA	-6.66
Net debt / equity	-0.97
Net debt / FCF	-3.62
Piotroski F-Score	4
Property, plant and equipment	$41M
Shareholders' equity	$538.1M
Tangible book value	$296.6M
Tangible book value per share	$1.18
Total assets	$994.3M
Total cash	$442.5M
Total debt	$23.2M
Total liabilities	$456.2M
WACC	10.4%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.58
Current assets	$589.7M
Current liabilities	$364.2M
Current ratio	1.62
Inventory turnover	9.78
Net working capital	$-211.3M
Quick ratio	1.52
Working capital	$225.5M
Working capital turnover	1.97

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-9.33%
Dividend yield	0%
Shareholder yield	-9.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$13.02
1D price change	-0.34%
1M price change	9.73%
1M total return	9.73%
1W price change	4.13%
1W total return	4.13%
1Y price change	-36%
1Y return CAGR	-36.02%
1Y total return	-36%
20-day SMA	$11.43
200-day SMA	$13.46
3M price change	-19.13%
3M total return	-19.13%
3Y price change	83.57%
3Y return CAGR	22.44%
3Y total return	83.57%
50-day SMA	$11.46
50-day SMA vs 200-day SMA	50under200
52-week high	$19.98
52-week high date	2025-11-13
52-week low	$9.58
52-week low date	2026-08-13
5Y price change	8.92%
5Y return CAGR	1.73%
5Y total return	8.92%
6M price change	-6.48%
6M total return	-6.48%
All-time high	$26.30
All-time high date	2025-02-06
All-time low	$3.80
All-time low date	2022-10-03
Average true range (ATR)	$0.40
Average volume	1.6M
Beta (1Y)	1.09
Beta (2Y)	0.67
Beta (5Y)	1.13
Change from 52-week high	-40.49%
Change from 52-week low	24.11%
Change from all-time high	-54.98%
Change from all-time low	211.58%
Change from open	0.08%
Day's gap	-0.42%
Dollar volume	$9.6M
High price	$12.11
Low price	$11.78
Monthly RSI	42.77
Open price	$11.88
Position in 52-week range	33.33%
Premarket change	-1.09%
Premarket close	$11.93
Premarket price	$11.80
Premarket volume	9.3K
Previous close	$11.93
Price vs 150-day SMA	-9.08%
Price vs 20-day SMA	3.6%
Price vs 200-day SMA	-12.01%
Price vs 50-day SMA	3.3%
Relative volume	0.51
RSI	54.37
Sharpe ratio	-0.47
Sharpe ratio (3Y)	0.54
Sharpe ratio (5Y)	0.21
Sortino ratio	-0.55
Sortino ratio (3Y)	0.89
Sortino ratio (5Y)	0.41
Volume	803.7K
Weekly RSI	45.67
YTD price change	-34.33%
YTD total return	-34.33%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	99.3M
Float percentage	39.59%
Shares change (QoQ)	0.28%
Shares change (YoY)	9.33%
Shares held by insiders	1.69%
Shares held by institutions	37.25%
Shares outstanding	250.8M
Short % of float	7.27%
Short % of shares	2.88%
Short ratio	2.9 days

Deeper analysis on CLBT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CLBT report

Is a complete CLBT research report available?

No complete published report is available for Cellebrite DI Ltd. (CLBT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Cellebrite DI Ltd. (CLBT)

Price

Financial snapshot

Fair-value bridge

Latest news · CLBT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CLBT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CLBT

Frequently asked questions